Cargando…

Biological therapies in monogenic autoinflammatory diseases: long-term efficacy and safety

Detalles Bibliográficos
Autores principales:	Pelagatti, Maria A, Cattoni, Alessandro, Rizzari, Carmelo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132537/ http://dx.doi.org/10.1186/1824-7288-40-S1-A26

Ejemplares similares

P03-014 - Biological therapy for autoinflammatory disorders
por: Rivas, S Bujan, et al.
Publicado: (2013)

Long-term efficacy and safety of biologics in rheumatoid arthritis
por: Montecucco, Carlomaurizio
Publicado: (2012)

The Autoinflammatory Diseases Alliance Registry of monogenic autoinflammatory diseases
por: Gaggiano, Carla, et al.
Publicado: (2022)

Biological Treatments: New Weapons in the Management of Monogenic Autoinflammatory Disorders
por: Vitale, Antonio, et al.
Publicado: (2013)

Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases
por: Bettiol, Alessandra, et al.
Publicado: (2019)

The expanding spectrum of rare monogenic autoinflammatory diseases
por: Touitou, Isabelle, et al.
Publicado: (2013)

Biochemistry of Autoinflammatory Diseases: Catalyzing Monogenic Disease
por: Beck, David B., et al.
Publicado: (2019)

Dermatologic and Dermatopathologic Features of Monogenic Autoinflammatory Diseases
por: Figueras-Nart, Ignasi, et al.
Publicado: (2019)

IL-1 inhibition in autoinflammatory diseases
por: Martini, Alberto
Publicado: (2012)

OR6-002 – Thromboembolism in autoinflammatory syndromes
por: Vaitla, PM, et al.
Publicado: (2013)

The classification, genetic diagnosis and modelling of monogenic autoinflammatory disorders
por: Moghaddas, Fiona, et al.
Publicado: (2018)

Monogenic Autoinflammatory Diseases: State of the Art and Future Perspectives
por: Di Donato, Giulia, et al.
Publicado: (2021)

Efficacy and safety of thalidomide in children with monogenic autoinflammatory diseases: a single-center, real-world-evidence study
por: Zhang, Caihui, et al.
Publicado: (2023)

PW02-001 - Exome sequencing for autoinflammatory disorders
por: Boyden, SE, et al.
Publicado: (2013)

PW03-034 – How to classify autoinflammatory diseases?
por: Grateau, G, et al.
Publicado: (2013)

PW02-023 - Qualitative aspects of autoinflammatory diseases
por: Konukbay, D, et al.
Publicado: (2013)

P02-007 - Childhood autoinflammatory disorders in Qatar
por: Aladbe, B, et al.
Publicado: (2013)

P03-023 – Autoinflammatory diseases database in Japan
por: Kawai, T, et al.
Publicado: (2013)

Efficacy and Safety of Janus Kinase Inhibitors in Type I Interferon-Mediated Monogenic Autoinflammatory Disorders: A Scoping Review
por: Gómez-Arias, Pedro Jesús, et al.
Publicado: (2021)

Long-term efficacy and safety of galantamine in outpatients with mild cognitive disorder
por: Zarra, Julio, et al.
Publicado: (2010)

PW03-035 – Autoinflammatory diseases diagnostic chart/tool
por: Durrant, KL, et al.
Publicado: (2013)

PW02-004 - Autoinflammatory syndromes: a clinical review
por: Biggs, CM, et al.
Publicado: (2013)

Management of Monogenic IL-1 Mediated Autoinflammatory Diseases in Childhood
por: Welzel, Tatjana, et al.
Publicado: (2021)

OR9-001 - Exome sequencing in monogenic Behçet-like disease
por: Zhou, Q, et al.
Publicado: (2013)

Monogenic Autoinflammatory Syndromes: State of the Art on Genetic, Clinical, and Therapeutic Issues
por: Caso, Francesco, et al.
Publicado: (2013)

Hints for Genetic and Clinical Differentiation of Adult-Onset Monogenic Autoinflammatory Diseases
por: Gaggiano, Carla, et al.
Publicado: (2019)

OR13-003 - TNFRSF11A molecular defects cause autoinflammatory disorders
por: Jéru, I, et al.
Publicado: (2013)

PW02-016 - 41 cases of TRAPS, a rare autoinflammatory disease
por: Chastang, M-C, et al.
Publicado: (2013)

Altered cytokine pattern and inflammatory pathways in monogenic and complex autoinflammatory diseases
por: Galozzi, P, et al.
Publicado: (2015)

A Pro-Inflammatory Signature Constitutively Activated in Monogenic Autoinflammatory Diseases
por: Galozzi, Paola, et al.
Publicado: (2022)

VEXAS syndrome: an adult-onset monogenic autoinflammatory disease with many unanswered questions
por: Hernández-Rodríguez, José, et al.
Publicado: (2023)

PW03-033 - SLC29A3 mutation: a new autoinflammatory condition
por: Melki, I, et al.
Publicado: (2013)

Monogenic Autoinflammatory Diseases with Mendelian Inheritance: Genes, Mutations, and Genotype/Phenotype Correlations
por: Martorana, Davide, et al.
Publicado: (2017)

The Many Faces of a Monogenic Autoinflammatory Disease: Adenosine Deaminase 2 Deficiency
por: Kendall, Jennifer Lee, et al.
Publicado: (2020)

VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases
por: Vitale, Antonio, et al.
Publicado: (2023)

Long-Term Follow-Up and Optimization of Interleukin-1 Inhibitors in the Management of Monogenic Autoinflammatory Diseases: Real-Life Data from the JIR Cohort
por: Hentgen, Véronique, et al.
Publicado: (2021)

Monogenic and multifactorial autoinflammatory diseases: Clinical and laboratory characterization in a pediatric Saudi population
por: Al-Mayouf, S, et al.
Publicado: (2015)

Monogenic autoinflammatory diseases in children: single center experience with clinical, genetic, and imaging review
por: Alsharief, Alaa N., et al.
Publicado: (2020)

Interleukin 1 inhibitors in monogenic autoinflammatory diseases – one size does not fit all
por: Więsik-Szewczyk, Ewa
Publicado: (2021)

Interferon in systemic lupus erythematosus—A halfway between monogenic autoinflammatory and autoimmune disease
por: Saulescu, Ioana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4ufic5239ujcr2fhqo3kas4tpt